基于脂纳米乳液的眼部滑剂用于治疗干眼子类型:多中心和前性研究
Maria Cristina Nishiwaki-Dantas1, Denise de Freitas1, Denise Fornazari2
1Department of Ophthalmology, Federal University of São Paulo, São Paulo, SP, Brazil.
Ophthalmology and therapy
|November 1, 2024
概括
这项研究表明,一种新的纳米乳液眼部滑剂通过改善膜稳定性和减少眼睛表面染色来有效治疗干眼病 (DED). 在患有缺水干眼症的患者中,治疗耐受性很好,包括混合型和蒸发型亚型.
科学领域:
- 眼科医生 眼科 眼科
- 眼睛表面疾病 眼睛表面疾病
- 眼部滑剂 眼部滑剂 眼部滑剂
背景情况:
- 干眼病 (DED) 是一种常见的眼睛表面疾病,影响膜平衡,导致不适和视力问题.
- 现有的治疗方法通常只针对水性缺陷,忽视了在蒸发性DED中常见的脂层缺陷.
- 一种具有脂纳米乳液 (PG-HPG-PH-N) 的新型烯基醇-基 guar旨在恢复脂质和水性膜层,以增强眼睛表面滑.
研究的目的:
- 评估PG-HPG-PH-N眼部滑剂在治疗DED时的有效性和安全性.
- 评估滑剂对膜稳定性和眼睛表面健康的影响.
- 为了确定滑剂的有效性,每天两次用于DED的水性缺乏,混合或蒸发性亚型.
主要方法:
- 一项前性,多中心,单臂研究,涉及70名患有DED的患者.
- 患者在28天内每天两次接受PG-HPG-PH-N滑剂.
- 评估包括眼睛表面疾病指数 (OSDI),纠正的视敏度,眼破裂时间 (TFBUT) 和眼睛表面染色.
主要成果:
- 70名患者 (60名女性,10名男性,平均年龄45岁) 完成了这项研究.
- 在14天和28天后,眼膜稳定性 (TFBUT) 显著改善,角膜染色减少.
- 眼部滑剂表现出良好的耐受性,没有报告任何重大不良事件.
结论:
- 该PG-HPG-PH-N纳米乳液是一种安全有效的眼部滑剂DED.
- 它成功地治疗了特征为缺水的DED亚型,包括混合和蒸发形式.
- 滑剂增强了膜的稳定性,并减少了眼睛表面的损伤.
相关概念视频
01:23Ophthalmic Drug Delivery Systems
284
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
284
01:22Microbiome of the Eye
75
The human eye has a specialized microbiota that reflects its unique anatomical and immunological environment. This low-biomass microbial community predominantly colonizes the conjunctiva and eyelid margins, playing a vital role in ocular surface homeostasis and defense. Despite its proximity to the richly colonized facial skin, the ocular surface maintains a distinct microbial profile due to continuous mechanical and biochemical defense mechanisms.The conjunctival surface hosts fewer microbial...
75